Biotech | August 20, 2021
Zydus Cadila receives Emergency Use Authorisation for 3-dose ZyCoV-D vaccine
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
Thermo Fisher’s kits leverage an updated design from the original TaqPath assays, targeting eight different genes across three regions of the virus that causes Covid-19
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
ZyCoV-D had already exhibited a robust immunogenicity and tolerability and safety profile in the adaptive Phase I/II clinical trials
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by ICMR and DCGI.
Subscribe To Our Newsletter & Stay Updated
